Advertisement

Annular lichenoid diseases

      Abstract

      Annular lichenoid diseases encompass a diverse range of pathologies that present as circular, raised, or flat lesions that may vary in size and number. Examples include annular lichenoid dermatitis of youth, annular lichen planus, erythema dyschromicum perstans, erythema multiforme, fixed drug eruption, lichen sclerosus, neonatal lupus, porokeratosis, subacute cutaneous lupus erythematosus, and lichenoid syphilis. Clinical morphology and histopathology can differentiate these entities.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinics in Dermatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pinkus H.
        Lichenoid tissue reactions: a speculative review of the clinical spectrum of epidermal basal cell damage with special reference to erythema dyschromicum perstans.
        Arch Dermatol. 1973; 107: 840-846
        • Wilson E.
        On leichen planus.
        J Cutan Med Dis Skin. 1869; 3: 117-132
        • Gru AA
        • Salavaggione AL.
        Lichenoid and interface dermatoses.
        Semin Diagn Pathol. 2017; 34: 237-249
        • Hsu S
        • Le EH
        • Khoshevis MR.
        Differential diagnosis of annular lesions.
        Am Fam Physician. 2001; 64: 289-296
        • Annessi G
        • Paradisi M
        • Angelo C
        • et al.
        Annular lichenoid dermatitis of youth.
        J Am Acad Dermatol. 2003; 49: 1029-1036
        • Cesinaro AM
        • Sighinolfi P
        • Greco A
        • et al.
        Annular lichenoid dermatitis of youth … and beyond: a series of 6 cases.
        Am J Dermatopathol. 2009; 31: 263-267
        • Kazlouskaya V
        • Trager JDK
        • Junkins-Hopkins JM.
        Annular lichenoid dermatitis of youth: a separate entity or on the spectrum of mycosis fungoides? Case report and review of the literature.
        J Cutan Pathol. 2015; 42: 420-426
        • Huh W
        • Kanitakis J.
        Annular lichenoid dermatosis of youth: report of the first Japanese case and published work review.
        J Dermatol. 2010; 37: 531-533
        • Di Mercurio M
        • Gisondi P
        • Colato C
        • et al.
        Annular lichenoid dermatitis of youth: report of six new cases with review of the literature.
        Dermatology. 2015; 231: 195-200
        • Weston G
        • Payette M.
        Update on lichen planus and its clinical variants.
        Int J Womens Dermatol. 2015; 1: 140-149
        • Lehman JS
        • Tollefson MM
        • Gibson LE
        Lichen planus.
        Int J Dermatol. 2009; 48: 682-694
        • Reich HL
        • Nguyen JT
        • James WD.
        Annular lichen planus: a case series of 20 patients.
        J Am Acad Dermatol. 2004; 50: 595-599
        • Mai S
        • Mansouri S
        • Hassam B.
        Annular atrophic lichen planus.
        BMJ Case Rep. 2019; : 12
        • Wagner G
        • Rose C
        • Sachse MM.
        Clinical variants of lichen planus.
        J Dtsch Dermatol Ges. 2013; 11: 309-319
        • Chang SE
        • Kim HW
        • Shin JM
        • et al.
        Clinical and histological aspect of erythema dyschromicum perstans in Korea: a review of 68 cases.
        J Dermatol. 2015; 42: 1053-1057
        • Leung N
        • Oliveira M
        • Selim MA
        • et al.
        Erythema dyschromicum perstans: a case report and systematic review of histologic presentation and treatment.
        Int J Womens Dermatol. 2018; 4: 216-222
        • Udompanich S
        • Vachiramon V.
        Acquired macular pigmentation of unknown etiology.
        J Clin Aesthet Dermatol. 2019; 12: 38-46
        • Kumarasinghe SPW
        • Pandya A
        • Chandran V
        • et al.
        A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.
        Int J Dermatol. 2018; 58: 263-272
        • Wang F
        • Zhao Y-K
        • Wang Z
        • et al.
        Erythema dyschromicum perstans response to isotretinoin.
        JAMA Dermatol. 2016; 152: 841
        • Abdel-Naser MB
        The color of skin: gray diseases of the skin, nails, and mucosa.
        Clin Dermatol. 2019; 37: 507-515
        • Silverberg NB
        • Herz J
        • Wagner A
        • et al.
        Erythema dyschromicum perstans in prepubertal children.
        Pediatr Dermatol. 2003; 20: 398-403
        • Lerch M
        • Mainetti C
        • Terziroli Beretta-Piccoli B
        • et al.
        Current perspectives on erythema multiforme.
        Clin Rev Allergy Immunol. 2018; 54: 177-184
        • Scully C
        • Bagan J.
        Oral mucosal diseases: erythema multiforme.
        Br J Oral Maxillofac Surg. 2008; 46: 90-95
        • Chen CW
        • Tsai TF
        • Chen YF
        • et al.
        Persistent erythema multiforme treated with thalidomide.
        Am J Clin Dermatol. 2008; 9: 123-127
        • Samim F
        • Auluck A
        • Zed C
        • et al.
        Erythema mulitforme.
        Den Clin North Am. 2013; 57: 583-596
        • Ayangco L
        • Rogers III, RS
        Oral manifestations of erythema multiforme.
        Dermatol Clin. 2003; 21: 195-205
        • Witte M
        • Zillikens D
        • Schmidt E.
        Diagnosis of autoimmune blistering diseases.
        Front Med (Lausanne). 2018; 5: 296
        • Hoetzenecker W
        • Nageli M
        • Mehra ET
        • et al.
        Adverse cutaneous drug eruptions: current understanding.
        Semin Immunopathol. 2016; 38: 75-86
        • Oak AS
        • Seminario-Vidal L
        • Sami N.
        Treatment of antiviral-resistant recurrent erythema multiforme with dapsone.
        Dermatol Ther. 2017; : 30
        • Sen P
        • Chua SH.
        A case of recurrent erythema multiforme and its therapeutic complications.
        Ann Acad Med Singapore. 2004; 33: 793-796
        • Bakis S
        • Zagarella S.
        Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme.
        Australas J Dermatol. 2005; 46: 18-20
        • Damsky W
        • King BA.
        Idiopathic erythema multiforme: evidence of underlying Janus kinase-signal transducer and activator of transcription activation and successful treatment with tofacitinib.
        JAAD Case Rep. 2016; : 502-504
        • Chen T
        • Levitt J
        • Geller L.
        Apremilast for treatment of recurrent erythema multiforme.
        Dermatol Online J. 2017; 23: 14
        • Flowers H
        • Brodell R
        • Brents M
        • et al.
        Fixed drug eruptions: presentation, diagnosis, and management.
        South Med J. 2014; 107: 724-727
        • Lee A-Y.
        Fixed drug eruptions.
        Am J Clinical Dermatol. 2000; 1: 277-285
        • Mizukawa Y
        • Yamazaki Y
        • Shiohara T.
        In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
        Br J Dermatol. 2008; 158: 1230-1238
        • Kornmehl H
        • Gorouhi F
        • Konia T
        • et al.
        Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
        Dermatol Online J. 2018; : 24
        • Jacobsen E
        • Tarabadkar ES
        • Shinohara MM.
        Generalized fixed drug eruption mimicking CD8+ cutaneous T-cell lymphoma in HIV.
        J Cutan Pathol. 2018; 46: 134-137
        • Lewis FM
        • Tatnall FM
        • Velangi SS
        • et al.
        British Association of Dermatologists guidelines for the management of lichen sclerosus, 2018.
        Br J Dermatol. 2018; 178: 839-853
        • Carlson JA
        • Lamb P
        • Malfetano J
        • et al.
        Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases.
        Mod Pathol. 1998; 11: 844-854
        • Sertznig P
        • von Felbert V
        • Megahed M.
        Porokeratosis: present concepts.
        J Eur Acad Dermatol Venereol. 2011; 26: 404-412
        • Zhang Z
        • Li C
        • Wu F
        • et al.
        Genomic variations of the mevalonate pathway in porokeratosis.
        eLife. 2015; 4
        • Kubo A
        • Sasaki T
        • Suzuki H
        • et al.
        Clonal expansion of second-hit cells with somatic recombinations or C>T transitions form porokeratosis in MVD or MVK mutant heterozygotes.
        J Investig Dermatol. 2019; 139 (e2459): 2458-2466
        • Biswas A.
        Cornoid lamellation revisited.
        Am J Dermatopathol. 2015; 37: 145-155
        • Atzmony L
        • Lim YH
        • Hamilton C
        • et al.
        Topical cholesterol/lovastatin for the treatment of porokeratosis: a pathogenesis-directed therapy.
        J Amer Acad Dermatol. 2020; 82: 123-131
        • Schwarz T
        • Seiser A
        • Gschnait F.
        Disseminated superficial “actinic” porokeratosis.
        J Am Acad Dermatol. 1984; 11: 724-730
        • Shumack S
        • Commens C
        • Kossard S.
        Disseminated superficial actinic porokeratosis: a histological review of 61 cases with particular reference to lymphocytic inflammation.
        Am J Dermatopathol. 1991; 13: 26-31
        • Weidner T
        • Illing T
        • Miguel D
        • et al.
        Treatment of porokeratosis: a systematic review.
        Am J Clin Dermatol. 2017; 18: 435-449
        • Atzmony L
        • Choate KA.
        Second-hit somatic mutations in mevalonate pathway genes underlie porokeratosis.
        J Investig Dermatol. 2019; 139: 2409-2411
        • Sasson M
        • Krain AD.
        Porokeratosis and cutaneous malignancy.
        Dermatol Surg. 1996; 22: 339-342
        • Lochner JC
        • Pomeranz JR.
        Lichenoid secondary syphilis.
        Arch Dermatol. 1974; 109: 81-83
        • Carbia SG
        • Lagodín C
        • Abbruzzese M
        • et al.
        Lichenoid secondary syphilis.
        Int J Dermatol. 1999; 38: 53-55
        • Monastirli A
        • Pasmatzi E
        • Georgiou S
        • et al.
        Lichen planus-like secondary syphilis in an 83-year-old woman.
        Clin Exp Dermatol. England. 2008; : 780-781
        • Khurana A
        • Singal A
        • Gupta S.
        Annular lichenoid syphilis: a rare entity.
        Indian J Sex Transm Dis AIDS. 2014; : 146-148
        • Narang T
        • De D
        • Dogra S
        • et al.
        Secondary syphilis presenting as annular lichenoid plaques on the scrotum.
        J Cutan Med Surg. 2008; 12: 114-116
        • Jeerapaet P
        • Ackerman AB.
        Histologic patterns of secondary syphilis.
        Arch Dermatol. 1973; 107: 373-377
        • Cohen PR
        • Carlos CA.
        Granuloma annulare mimicking sarcoidosis: report of patient with localized granuloma annulare whose skin lesions show 3 clinical morphologies and 2 histology patterns.
        Am J Dermatopathol. 2015; 37: 547-550